Manufacturer
argenx
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 1
argenx is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- argenx US
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply argenx products through licensed channels, with the documents your regulator needs.
Immunology and transplant
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vyvgart 400 mg/20 mL injectionIntravenous Cold chain | Efgartigimod alfa | US FDA | Available on request |
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| VYVGART Hytrulo 180 mg/2000 units per mL injectionSubcutaneous Cold chain | Efgartigimod alfa and Hyaluronidase (human recombinant) | US FDA | Available on request |
| VYVGART Hytrulo 200 mg/2000 units per mL injectionSubcutaneous Cold chain | Efgartigimod alfa and Hyaluronidase (human recombinant) | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from argenx
Send a request for any of these products. We confirm the licensed source, documents and lead time.